Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study Two

ClinicalTrials.gov ID: NCT00548405

Public ClinicalTrials.gov record NCT00548405. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 25, 2026, 11:12 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Rater- and Dose-Blinded Study Comparing Two Annual Cycles of Intravenous Low- and High-Dose Alemtuzumab to Three-Times Weekly Subcutaneous Interferon Beta 1a (Rebif®) in Patients With Relapsing Remitting Multiple Sclerosis Who Have Relapsed On Therapy

Study identification

NCT ID
NCT00548405
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Genzyme, a Sanofi Company
Industry
Enrollment
840 participants

Conditions and interventions

Interventions

  • Alemtuzumab 12 mg Biological
  • Alemtuzumab 24 mg Biological
  • Interferon beta-1a Biological

Biological

Eligibility (public fields only)

Age range
18 Years to 55 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 30, 2007
Primary completion
Aug 31, 2011
Completion
Aug 31, 2011
Last update posted
Apr 16, 2017

2007 – 2011

United States locations

U.S. sites
85
U.S. states
34
U.S. cities
74
Facility City State ZIP Site status
North Central Neurology Associates, P.C. Cullman Alabama
Barrow Neurological Institute, St. Joseph's Hospital and Medical Center Phoenix Arizona
Hope Research Institute Phoenix Arizona
Mayo Clinic Arizona, Department of Neurology Scottsdale Arizona
Northwest NeuroSpecialists, PLLC Tucson Arizona
East Bay Physicians Medical Group/Sutter East Bay Medical Foundation Berkeley California
Neurology Center of North Orange County La Habra California
Department of Neurology, Keck School of Medicine, University of Southern California Los Angeles California
Neuro-Therapeutics Inc. Pasadena California
Neuro-Therapeutics, Inc Pasadena California
University of California, Davis Medical Center Sacramento California
Stanford University School of Medicine Stanford California
University of Colorado Hospital, Anschutz Outpatient Pavilioin Aurora Colorado
Neurological Consultants Denver Colorado
Advanced Neurosciences Research Fort Collins Colorado
Yale University New Haven Connecticut
George Washington University Medical Faculty Associates Washington D.C. District of Columbia
University of Florida Neuroscience Institute Jacksonville Florida
Neurology Associates, P.A. Maitland Florida
Neurological Associates Pompano Beach Florida
Negroski, Stein, Sutherland and Hanes Neurology Sarasota Florida
Axiom Clinical Research of Florida Tampa Florida
University of South Florida, Department of Neurology Tampa Florida
Emory University, Department of Neurology Atlanta Georgia
Shepherd Center, Inc. Atlanta Georgia
Idaho Falls Multiple Sclerosis Center, PLLC Idaho Falls Idaho
University of Chicago Medical Center, Department of Neurology Chicago Illinois
Consultants in Neurology, Ltd Northbrook Illinois
Fort Wayne Neurological Center Fort Wayne Indiana
Indiana University School of Medicine, Department of Neurology Indianapolis Indiana
Josephson Wallack Munshower Neurology P.C. Indianapolis Indiana
Iowa Health Physicians Des Moines Iowa
Ruan Neurology Clinic and Research Center Des Moines Iowa
University of Kansas Medical Center, Department of Neurology Kansas City Kansas
MidAmerica Neuroscience Institute Lenexa Kansas
Associates in Neurology, PSC Lexington Kentucky
University of Louisville Research Foundation Louisville Kentucky
Louisiana State University Health Sciences Center Shreveport Louisiana
Caritas St. Elizabeth's Medical Center Boston Massachusetts
Partners Multiple Sclerosis Center/Brigham and Women's Hospital Boston Massachusetts
Springfield Neurology Associates, LLC Springfield Massachusetts
UMass Memorial Medical Center Worcester Massachusetts
University of Michigan Department of Neurology Ann Arbor Michigan
Henry Ford Hospital Detroit Michigan
Wayne State University, School of Medicine, Department of Neurology Detroit Michigan
Spectrum Health Medical Group, Neurology (Previously known as Michigan Medical P.C., Neurology) Grand Rapids Michigan
Michigan Neurology Associates, P.C. Saint Clair Shores Michigan
Northern Michigan Neurology Traverse City Michigan
Mayo Clinic Rochester Rochester Minnesota
Neurology Consultants of Kansas City, Inc. Kansas City Missouri
Montana Neurobehavioral Specialists Missoula Montana
University of Nevada School of Medicine Las Vegas Nevada
Renown Institute for Neurosciences / Renown regional Medical Center Reno Nevada
Dartmouth-Hitchcock Medical Center, Norris Cotton Cancer Center Lebanon New Hampshire
MS Center at Holy Name Hospital Teaneck New Jersey
University of New Mexico, Health Sciences Center, MS Specialty Clinic Albuquerque New Mexico
Empire Neurology, PC Latham New York
Winthrop University Hospital, Clinical Trials Center Mineola New York
Mount Sinai School of Medicine, Corinne Goldsmith Dickinson Center for Multiple Sclerosis New York New York
Comprehensive Multiple Sclerosis Care Center at South Shore Neurologic Associates, P.C. Patchogue New York
University of Rochester Medical Center Rochester New York
SUNY Upstate Medical University, Department of Neurology Syracuse New York
University of North Carolina-Chapel Hill, Department of Neurology Chapel Hill North Carolina
Wake Forest University Health Science, Department of Neurology Winston-Salem North Carolina
Cleveland Clinic Foundation, Mellen Center Cleveland Ohio
Neurology Specialists, Inc. Dayton Ohio
Oak Clinic for Multiple Sclerosis Uniontown Ohio
MS Center of Oklahoma Oklahoma City Oklahoma
Lehigh Valley Hospital, Neuroscience and Pain Research Allentown Pennsylvania
Northshore Clinical Associates Erie Pennsylvania
University of Pittsburgh, Kaufmann Medical Building Pittsburgh Pennsylvania
The Neurology Foundation, Inc. Providence Rhode Island
Neurology Clinic, P.C. Cordova Tennessee
Advanced Neurosciences Institute Franklin Tennessee
Biomedical Research Alliance of NY, LLC Franklin Tennessee
Hope Neurology PC Knoxville Tennessee
Vanderbilt Multiple Sclerosis Center Nashville Tennessee
Clinical Center for Multiple Sclerosis Dallas Texas
Central Texas Neurology Round Rock Texas
Integra Clinical Research San Antonio Texas
Neurology Center of San Antonio San Antonio Texas
MS Center of Greater Washington, P.C. Vienna Virginia
Swedish Neuroscience Institute Seattle Washington
Virginia Mason Medical Center Seattle Washington
Rockwood Clinical Research Center Spokane Washington

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 106 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00548405, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 16, 2017 · Synced Jun 25, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00548405 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →